{"@id":"https://bioecon.ru/technology/therapeutic-plasma-exchange-plasma-fractions/","@type":"Technology","cluster":"regenerative-personalized","formats":{"html":"https://cn.bioecon.ru/technology/therapeutic-plasma-exchange-plasma-fractions/","json":"https://cn.bioecon.ru/api/v1/technology/therapeutic-plasma-exchange-plasma-fractions/index.json"},"id":"therapeutic-plasma-exchange-plasma-fractions","industries":["longevity"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/longevity/"],"suppliers":["https://bioecon.ru/companies/agro-koni/","https://bioecon.ru/companies/altos-labs/","https://bioecon.ru/companies/yeruva-sa/","https://bioecon.ru/companies/bioviva/","https://bioecon.ru/companies/united-therapeutics/","https://bioecon.ru/companies/delta-beverages-pvt-ltd/","https://bioecon.ru/companies/bioage-labs/","https://bioecon.ru/companies/fountain-life/","https://bioecon.ru/companies/amazentis/"]},"maturity":null,"name":"治疗性血浆置换与血浆组分“逆龄”","regions":["us"],"risk":"high","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-09","entity":"alzdiscovery.org","kind":"web","urls":["https://www.alzdiscovery.org/uploads/cognitive_vitality_media/Plasma_exchange.pdf"]},{"date":"2026-11-09","entity":"link.springer.com","kind":"research","urls":["https://link.springer.com/article/10.1007/s11357-026-02435-0"]},{"date":"2026-11-09","entity":"fda.gov","kind":"official","urls":["https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/update-important-information-about-young-donor-plasma-infusions-offered-profit"]},{"date":"2026-11-09","entity":"pmc.ncbi.nlm.nih.gov","kind":"research","urls":["https://pmc.ncbi.nlm.nih.gov/articles/PMC13001061/"]}],"stages":[{"n":1,"title":"明确适应症"},{"n":2,"title":"核对监管要求"},{"n":3,"title":"权衡风险"}],"summary":"血浆置换已用于特定神经与自身免疫疾病，而非抗衰老；年轻供体血浆尚无抗衰老效果证据，并受FDA严格管控。","url":"/technology/therapeutic-plasma-exchange-plasma-fractions/","verified":"2026-11-09"}